LEADER 01134nam--2200385---450 
001 990005837730203316
005 20240213134430.0
010   $a978-0-12-404717-4
035   $a000583773
035   $aUSA01000583773
035   $a(ALEPH)000583773USA01
035   $a000583773
100   $a20130503d2012----km-y0itay50------ba
101   $aeng
102   $aGB
105   $a||||||||001yy
200 1 $aImmunopharmacology$fedited by David R. Webb$gserial editor, S.J. Enna$Gmanaging editor, Lynn LeCourt
210   $aElsevier$cAmsterdam [etc.]$d2012
215   $aXI, 333 p.$d23 cm
225 2 $aAdvances in pharmacology$v66
410  0$1001000609420$12001$aAdvances in pharmacology$v66
606   $aFarmacologia$2BNCF
606 0 $aImmunoterapia$2BNCF
676   $a616.079
702  1$aWEBB,$bDavid R.
702  1$aENNA,$bS.J.
702  1$aLECOURT,$bLynN
801  0$aIT$bsalbc$gISBD
912   $a990005837730203316
951   $a615 AIP/66$b5676 FARM$c615$d00292025
959   $aBK
969   $aFAR
979   $aIANNONE$b90$c20130503$lUSA01$h1008
996   $aImmunopharmacology$9396397
997   $aUNISA